Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Guangdong Geriatric Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Search for other papers by Qinglei Yin in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Zhou Jin in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Reproductive Medicine Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Search for other papers by Dalong Song in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Chenyang Fu in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Search for other papers by FengJiao Huang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Shu Wang in
Google Scholar
PubMed
–4 months and reached normal free triiodothyronine (FT 3 ) and free thyroxine (FT 4 ) levels. GD patients in remission had been treated with MMI for at least 10 months and maintained FT 3 , FT 4 , TSH and TRAb levels in normal range for at least 3 months
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
serum thyroid hormone levels and suppressed TSH, diffuse enlargement of the thyroid gland, and TRAb are positive. Laboratory methods Fasting serum GH, IGF-1, total triiodothyronine (TT3), total thyroxine (TT4), TSH, free triiodothyronine (FT3
Search for other papers by Danzhou Fang in
Google Scholar
PubMed
Search for other papers by Shiying Li in
Google Scholar
PubMed
Search for other papers by Changgu Zhou in
Google Scholar
PubMed
Search for other papers by Yirui Wang in
Google Scholar
PubMed
Search for other papers by Gengbiao Yuan in
Google Scholar
PubMed
Search for other papers by HuiHui Zhang in
Google Scholar
PubMed
Search for other papers by Maohua Rao in
Google Scholar
PubMed
evaluation, the main indexes were free tri-iodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH). The therapeutic effect was assessed at the 2-month follow-up based on liver and thyroid function indexes. Treatment outcomes were
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Chiara Mele in
Google Scholar
PubMed
Search for other papers by Maria Teresa Samà in
Google Scholar
PubMed
Search for other papers by Alessandro Angelo Bisoffi in
Google Scholar
PubMed
Search for other papers by Marina Caputo in
Google Scholar
PubMed
Search for other papers by Valentina Bullara in
Google Scholar
PubMed
Search for other papers by Stefania Mai in
Google Scholar
PubMed
Search for other papers by Gillian Elisabeth Walker in
Google Scholar
PubMed
Search for other papers by Flavia Prodam in
Google Scholar
PubMed
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Paolo Marzullo in
Google Scholar
PubMed
Search for other papers by Gianluca Aimaretti in
Google Scholar
PubMed
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy
Search for other papers by Loredana Pagano in
Google Scholar
PubMed
-stimulating hormone (TSH), free thyroxine (fT4) and free triiodothyronine (fT3) using an automated chemiluminescence assay system (ADVIA Centaur Systems TSH3/fT4/fT3 Ultra Ready Pack, Siemens Healthcare Diagnostics). Serum levels of thyroglobulin (Tg) were
Search for other papers by Qingrong Pan in
Google Scholar
PubMed
Search for other papers by Shuxin Gao in
Google Scholar
PubMed
Search for other papers by Xia Gao in
Google Scholar
PubMed
Search for other papers by Ning Yang in
Google Scholar
PubMed
Search for other papers by Zhi Yao in
Google Scholar
PubMed
Search for other papers by Yanjin Hu in
Google Scholar
PubMed
Search for other papers by Li Miao in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
normal ranges. The normal values for TSH, free triiodothyronine (FT3) and free thyroxine (FT4) were 0.55–4.78 μIU/mL, 2.3–4.2 pg/mL and 8.9–17.6 pg/mL, respectively. Exclusion criteria were as follows: patients under treatment with thyroxine, or anti
Search for other papers by Xia Wu in
Google Scholar
PubMed
Search for other papers by Zhiling Li in
Google Scholar
PubMed
Search for other papers by Wenjiang Sun in
Google Scholar
PubMed
Search for other papers by Huan Zheng in
Google Scholar
PubMed
-C, LDL-C, TG, creatinine (Cr), uric acid (UA), free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH), TT (total testosterone), and Hcy levels were recorded. Hcy values were determined with an assay kit (MAKER, China) based
Search for other papers by Melinda Kertész in
Google Scholar
PubMed
Search for other papers by Szilárd Kun in
Google Scholar
PubMed
Search for other papers by Eszter Sélley in
Google Scholar
PubMed
Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed
Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed
Search for other papers by István Wittmann in
Google Scholar
PubMed
derangements. Insulin signaling uses many pathways, but the glucometabolic effect is mediated through a PI3K route. Canonical intracellular signaling of free triiodothyronine (T3) in turn, the so-called type 1 and 2 pathway, involves direct and indirect DNA
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Shanshan Yu in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Chun Liu in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
triiodothyronine, thyroxine, free triiodothyronine (FT3), free thyroxine (FT4), ultrasensitive thyroid-stimulating hormone (uTSH), thyroid peroxidase antibody (TPOAb), thyroid antithyroglobulin autoantibody (TgAb) and parathyroid hormone were detected by an
Search for other papers by Sílvia Santos Monteiro in
Google Scholar
PubMed
Search for other papers by Tiago Silva Santos in
Google Scholar
PubMed
Search for other papers by Ana Martins Lopes in
Google Scholar
PubMed
Search for other papers by José Carlos Oliveira in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
test following 1000 µg of oral LT4 intake ( 9 , 10 , 11 ). At the patient’s admission, a peripheral i.v. catheter was inserted and a baseline blood sample was collected for TSH, free thyroxine (FT4) and free triiodothyronine (FT3) measurements. Then
Search for other papers by Isabel M Abreu in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Search for other papers by Eva Lau in
Google Scholar
PubMed
Search for other papers by Bernardo de Sousa Pinto in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is diagnosed biochemically when both serum-free thyroxine (FT4) and free triiodothyronine (FT3) are within the normal range, whereas the serum thyroid-stimulating hormone (TSH) is elevated ( 1